AAAAAA

   
Results: 1-13 |
Results: 13
CLINICAL-EVALUATION OF 2 DOSAGES AND SCHEDULES OF IFOSFAMIDE IN COMBINATION WITH CISPLATIN IN NEOADJUVANT CHEMOTHERAPY OF PATIENTS WITH ADVANCED (STAGE III-IV) HEAD AND NECK SQUAMOUS-CELL CARCINOMA - A PHASE-II RANDOMIZED STUDY
Authors: MANTOVANI G GHIANI M LAI P MACCIO A DESSI D SUCCU G MASSA D CURRELI L MULAS C ESU S PROTO E CADEDDU G TORE G
Citation: G. Mantovani et al., CLINICAL-EVALUATION OF 2 DOSAGES AND SCHEDULES OF IFOSFAMIDE IN COMBINATION WITH CISPLATIN IN NEOADJUVANT CHEMOTHERAPY OF PATIENTS WITH ADVANCED (STAGE III-IV) HEAD AND NECK SQUAMOUS-CELL CARCINOMA - A PHASE-II RANDOMIZED STUDY, Oncology Reports, 5(6), 1998, pp. 1499-1505
MEDROXYPROGESTERONE ACETATE AND MEGESTROL-ACETATE REDUCE CISPLATIN-INDUCED SEROTONIN RELEASE FROM HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS OF CANCER-PATIENTS
Authors: MANTOVANI G MACCIO A LAI P ESU S MASSA E SANTONA MC MASSA D DESSI D GHIANI M
Citation: G. Mantovani et al., MEDROXYPROGESTERONE ACETATE AND MEGESTROL-ACETATE REDUCE CISPLATIN-INDUCED SEROTONIN RELEASE FROM HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS OF CANCER-PATIENTS, Oncology Reports, 5(1), 1998, pp. 121-124
PREVENTION OF ACUTE EMESIS IN CANCER-PATIENTS RECEIVING HIGH-DOSE CISPLATIN (HD-CDDP) - COMPARISON OF TRANSDERMAL FENTANYL (TTS-F) VS IV ONDANSETRON (OND), BOTH COMBINED WITH DEXAMETHASONE (D)
Authors: CURRELI L GHIANI M DESSI D MASSA D MULAS C SUCCU G MANTOVANI G
Citation: L. Curreli et al., PREVENTION OF ACUTE EMESIS IN CANCER-PATIENTS RECEIVING HIGH-DOSE CISPLATIN (HD-CDDP) - COMPARISON OF TRANSDERMAL FENTANYL (TTS-F) VS IV ONDANSETRON (OND), BOTH COMBINED WITH DEXAMETHASONE (D), Annals of oncology, 9, 1998, pp. 712-712
NEOADJUVANT CHEMO-(IMMUNO-)THERAPY OF ADVANCED SQUAMOUS-CELL HEAD ANDNECK-CARCINOMA - A MULTICENTER, PHASE-III, RANDOMIZED STUDY COMPARINGCISPLATIN PLUS 5-FLUOROURACIL [5-FU] WITH CISPLATIN PLUS 5-FU PLUS RECOMBINANT INTERLEUKIN-2
Authors: MANTOVANI G GEBBIA V AIROLDI M BUMMA C CONTU P BIANCHI A GHIANI M DESSI D MASSA E CURRELI L LAMPIS B LAI P MULAS C TESTA A PROTO E CADEDDU G TORE G
Citation: G. Mantovani et al., NEOADJUVANT CHEMO-(IMMUNO-)THERAPY OF ADVANCED SQUAMOUS-CELL HEAD ANDNECK-CARCINOMA - A MULTICENTER, PHASE-III, RANDOMIZED STUDY COMPARINGCISPLATIN PLUS 5-FLUOROURACIL [5-FU] WITH CISPLATIN PLUS 5-FU PLUS RECOMBINANT INTERLEUKIN-2, Cancer immunology and immunotherapy, 47(3), 1998, pp. 149-156
LEVELS OF IL-4, IL-10 AND INF-GAMMA IN THE SERUM AND IN THE PBMC CULTURE SUPERNATANTS FROM 31 PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
Authors: MANTOVANI G MACCIO A ESU S LAI P MASSA E DESSI D
Citation: G. Mantovani et al., LEVELS OF IL-4, IL-10 AND INF-GAMMA IN THE SERUM AND IN THE PBMC CULTURE SUPERNATANTS FROM 31 PATIENTS WITH HEMATOLOGICAL MALIGNANCIES, British Journal of Haematology, 102(1), 1998, pp. 118-118
TUMOR-ASSOCIATED LYMPHOMONOCYTES (TALM) FROM NEOPLASTIC EFFUSIONS SECONDARY TO OVARIAN-CANCER ARE IMMUNOLOGICALLY DEFECTIVE BUT ARE ABLE TORELEASE CYTOKINES
Authors: MANTOVANI G MACCIO A LAI P ESU S GHIANI M DESSI D MASSA E MELIS GB DELGIACCO GS
Citation: G. Mantovani et al., TUMOR-ASSOCIATED LYMPHOMONOCYTES (TALM) FROM NEOPLASTIC EFFUSIONS SECONDARY TO OVARIAN-CANCER ARE IMMUNOLOGICALLY DEFECTIVE BUT ARE ABLE TORELEASE CYTOKINES, Oncology Reports, 4, 1997, pp. 247-251
CLINICAL AND IMMUNOLOGICAL EVALUATION OF SCHIZOPHYLLAN (SPG) IN COMBINATION WITH STANDARD CHEMOTHERAPY IN PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA
Authors: MANTOVANI G BIANCHI A CURRELI L GHIANI M ASTARA G LAMPIS B SANTONA MC DESSI D ESU S LAI P MASSA E MACCIO A PROTO E
Citation: G. Mantovani et al., CLINICAL AND IMMUNOLOGICAL EVALUATION OF SCHIZOPHYLLAN (SPG) IN COMBINATION WITH STANDARD CHEMOTHERAPY IN PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA, International journal of oncology, 10(1), 1997, pp. 213-221
MEDROXYPROGESTERONE ACETATE REDUCES THE IN-VITRO PRODUCTION OF CYTOKINES AND SEROTONIN INVOLVED IN ANOREXIA CACHEXIA AND EMESIS BY PERIPHERAL-BLOOD MONONUCLEAR-CELLS OF CANCER-PATIENTS/
Authors: MANTOVANI G MACCIO A ESU S LAI P SANTONA MC MASSA E DESSI D MELIS GB DELGIACCO GS
Citation: G. Mantovani et al., MEDROXYPROGESTERONE ACETATE REDUCES THE IN-VITRO PRODUCTION OF CYTOKINES AND SEROTONIN INVOLVED IN ANOREXIA CACHEXIA AND EMESIS BY PERIPHERAL-BLOOD MONONUCLEAR-CELLS OF CANCER-PATIENTS/, European journal of cancer, 33(4), 1997, pp. 602-607
MEDROXYPROGESTERONE ACETATE REDUCES THE PRODUCTION OF CYTOKINES AND SEROTONIN INVOLVED IN ANOREXIA CACHEXIA AND EMESIS BY PERIPHERAL-BLOOD MONONUCLEAR-CELLS OF CANCER-PATIENTS/
Authors: MANTOVANI G MACCIO A ESU S LAI P SANTONA MC MASSA E DESSI D MELIS G DELGIACCO S
Citation: G. Mantovani et al., MEDROXYPROGESTERONE ACETATE REDUCES THE PRODUCTION OF CYTOKINES AND SEROTONIN INVOLVED IN ANOREXIA CACHEXIA AND EMESIS BY PERIPHERAL-BLOOD MONONUCLEAR-CELLS OF CANCER-PATIENTS/, Biochemical Society transactions, 25(2), 1997, pp. 296-296
TUMOR-ASSOCIATED LYMPHO-MONOCYTES FROM NEOPLASTIC EFFUSIONS ARE IMMUNOLOGICALLY DEFECTIVE IN COMPARISON WITH PATIENT AUTOLOGOUS PBMCS BUT ARE CAPABLE OF RELEASING HIGH AMOUNTS OF VARIOUS CYTOKINES
Authors: MANTOVANI G MACCIO A PISANO M VERSACE R LAI P ESU S MASSA E GHIANI M DESSI D MELIS GB DELGIACCO GS
Citation: G. Mantovani et al., TUMOR-ASSOCIATED LYMPHO-MONOCYTES FROM NEOPLASTIC EFFUSIONS ARE IMMUNOLOGICALLY DEFECTIVE IN COMPARISON WITH PATIENT AUTOLOGOUS PBMCS BUT ARE CAPABLE OF RELEASING HIGH AMOUNTS OF VARIOUS CYTOKINES, International journal of cancer, 71(5), 1997, pp. 724-731
NEOADJUVANT (PRIMARY) ORGAN-PRESERVING CHEMOTHERAPY IN THE MANAGEMENTOF LOCALLY ADVANCED LARYNGEAL CARCINOMA - LARYNX PRESERVATION AND CLINICAL-RESPONSE
Authors: MANTOVANI G GEBBIA V PROTO E COSSU F BIANCHI A CURRELI L GHIANI M MASSA E ASTARA G LAMPIS B DESSI D SANTONA MC
Citation: G. Mantovani et al., NEOADJUVANT (PRIMARY) ORGAN-PRESERVING CHEMOTHERAPY IN THE MANAGEMENTOF LOCALLY ADVANCED LARYNGEAL CARCINOMA - LARYNX PRESERVATION AND CLINICAL-RESPONSE, International journal of oncology, 9(5), 1996, pp. 1035-1043
NEOADJUVANT ORGAN-PRESERVING CHEMOTHERAPY IN THE MANAGEMENT OF LOCALLY ADVANCED ORAL CAVITY AND OROPHARYNX CANCER - A TENTATIVE QUANTITATIVE-EVALUATION OF ORGAN PRESERVATION AND CLINICAL-RESPONSE
Authors: MANTOVANI G GEBBIA V PROTO E COSSU F BIANCHI A CURRELI L GHIANI M ASTARA G LAMPIS B DESSI D SANTONA MC MASSA E
Citation: G. Mantovani et al., NEOADJUVANT ORGAN-PRESERVING CHEMOTHERAPY IN THE MANAGEMENT OF LOCALLY ADVANCED ORAL CAVITY AND OROPHARYNX CANCER - A TENTATIVE QUANTITATIVE-EVALUATION OF ORGAN PRESERVATION AND CLINICAL-RESPONSE, International journal of oncology, 9(3), 1996, pp. 571-578
TUMOR-ASSOCIATED LYMPHOCYTES (TAL) ARE COMPETENT TO PRODUCE HIGHER LEVELS OF CYTOKINES IN NEOPLASTIC PLEURAL AND PERITONEAL EFFUSIONS THAN THOSE FOUND IN SERA AND ARE ABLE TO RELEASE INTO CULTURE HIGHER LEVELSOF IL-2 AND IL-6 THAN THOSE RELEASED BY PBMC
Authors: MANTOVANI G MACCIO A VERSACE R PISANO M LAI P ESU S GHIANI M DESSI D TURNU E SANTONA MC CHERCHI R DELGIACCO GS
Citation: G. Mantovani et al., TUMOR-ASSOCIATED LYMPHOCYTES (TAL) ARE COMPETENT TO PRODUCE HIGHER LEVELS OF CYTOKINES IN NEOPLASTIC PLEURAL AND PERITONEAL EFFUSIONS THAN THOSE FOUND IN SERA AND ARE ABLE TO RELEASE INTO CULTURE HIGHER LEVELSOF IL-2 AND IL-6 THAN THOSE RELEASED BY PBMC, Journal of molecular medicine, 73(8), 1995, pp. 409-416
Risultati: 1-13 |